Listed Company

Polynovo Ltd (ASX PNV)

Polynovo is an Australian company founded in 1998 by spinning off projects originating from the CSIRO. PNV is an Australian healthcare equipment and services company that designs and develops equipment for the treatment of burns, surgical wounds and Negative Pressure Wound Therapy and operates in Australia and has a global reach. The company headquarters are in Melbourne, Australia and it's shares trade publicly on the ASX.


Followers 218
Exchange ASX
Sector Healthcare
Industry Health Care Equipment & Services

Watch

Latest News on Polynovo Ltd


Frequently Asked Questions

Featuring answers to some of the most frequent questions asked by investors about Polynovo Ltd
Company History
Was Polynovo created by the CSIRO?
PolyNovo Biomaterials was formed in 2004, as a joint venture between CSIRO and Xceed Biotechnology. The CSIRO continues to support the spin off company to further advance materials and device development programs through collaborative research schemes and consulting services.
Dividends
Does Polynovo (PNV) pay dividends?
No, Polynovo Ltd (PNV) does not have a history of paying dividends.
Purchase Shares
Where can I buy Polynovo (PNV) shares?
An individual can buy and sell shares with the assistance of a broker who is licensed to trade on the ASX (Australian Securities Exchange).

Covering Polynovo Ltd


Buy Hold Sell
Livewire Markets
James Gerrish
Market Matters
Carl Capolingua
Livewire Markets
Mark Gardner
MPC Markets
Gary Rollo
Montgomery
Joseph Kim

Polynovo Ltd (ASX:PNV) is an Australian publicly listed company that trades on the Australian Stock Exchange. The company's stock code is PNV. Livewire Markets has 27 experts who have published 66 articles that have featured Polynovo Ltd. You can view all those wires here. The last time time PNV was featured was on the 15 November 2024 by Carl Capolingua in the wire “ASX stocks Trump Trade Playbook”. Get the latest PNV share price and other key information like PNV Financials on Market Index.